ライフサイエンスコーパス: YAG

1 YAG laser vitreolysis subjectively improved Weiss ring-r

2 YAG vitreolysis is an untested treatment for floaters.

3 2 of the 5' GU, and all positions of the 3' YAG.

4 itical sequences at both the 5' (GU) and 3' (YAG) ends of the intron.

5 that were induced by mutations outside the 3'YAG consensus (designated 'de novo') were in introns.

6 as those resulting from a mutation of the 3'YAG consensus, were more frequent in exons than in intro

7 to experimental data on a sensitized Nd(3+):YAG cavity, and quantitative agreement with theoretical

8 ometrists submitted a total of 7521 and 3751 YAG laser capsulotomy claims to Medicare, respectively.

9 distribution identifies the optimal motif 5'-YAG-3' and shows how its copy number, position in the lo

10 rists who submitted claims to Medicare for a YAG laser capsulotomy, and the county addresses of the c

11 yes (82.5%), and 42 eyes (52.5%) underwent a YAG laser capsulotomy at a mean of 10.8 months after sur

12 s plana vitrectomy, phacoemulsification, and YAG capsulotomy into one procedure.

13 We report a 750-mum-thick Nd(3+)-doped YAG planar waveguide sensitized by a luminescent CdSe/Cd

14 able response rates (CO2 laser, 50%-100%; Er:YAG laser, 72%-100%; PDL, 47%-100%; and Nd:YAG laser, 46

15 newed method comprises the output of an a Er:YAG laser at lambda = 2.94 mum which is in resonance wit

16 gher surface roughness was achieved after Er:YAG laser treatment.

17 rial with either a dental handpiece or an Er:YAG laser (350 mJ/pulse at 6 Hz) by raster-scanning the

18 on of the dentinal surface with either an Er:YAG laser (lambda = 2.94 microns) or a standard dental b

19 An Er:YAG laser coupled with a cooling stream of water effecti

20 ed from disposable 30-gauge needles to an Er:YAG laser.

21 This LRD technique utilizes an Er:YAG rotary Q-switched laser with an output wavelength of

22 Both diode and Er:YAG lasers gave excellent results in gingival hyperpigme

23 The (80 at.%) Er:YAG crystal is opaque between 1.45 mum and 1.64 mum.

24 4 W, continuous wave),and "brushstroke" (Er:YAG laser, 180 mJ, 10 Hz, long pulse) techniques.

25 ival debridement followed 1 week later by Er:YAG application in sites with initial probing depths [PD

26 oablative deepithelialization with either Er:YAG or diode laser.

27 al tip is less efficient than high-energy Er:YAG irradiation to remove the plaque and TiO2 layer on a

28 5 groups: HF (hydrofluoric acid-etching), Er:YAG laser + HF, Graphite + Er:YAG laser + HF, Nd:YAG las

29 gave statistically significant values for Er:YAG laser depigmentation (P = 0.001).

30 either an erbium:yttrium-aluminum-garnet (Er:YAG) (2,940-nm) laser or a diode (660-nm) laser in combi

31 l lasers, erbium:yttrium-aluminum-garnet (Er:YAG) and diode, for the treatment of gingival hyperpigme

32 ficacy of erbium:yttrium-aluminum-garnet (Er:YAG) laser application as an adjunct to subgingival debr

33 versus an erbium:yttrium-aluminum-garnet (Er:YAG) laser on titanium surfaces contaminated with subgin

34 bium-doped:yttrium, aluminum, and garnet (Er:YAG) laser techniques for gingival depigmentation and to

35 de (CO2), erbium:yttrium-aluminum-garnet (Er:YAG), pulsed dye (PDL), and Nd:YAG have been investigate

36 d-etching), Er:YAG laser + HF, Graphite + Er:YAG laser + HF, Nd:YAG laser + HF, and Graphite + Nd:YAG

37 CC) in 2 cases using RCM imaging to guide Er:YAG laser ablation.

38 ation remains the gold standard; however, Er:YAG laser and CO2 lasers can be effectively used but wit

39 However, Er:YAG laser induced deeper gingival tissue injury than dio

40 A 2.94-microm Er:YAG laser for IR atmospheric pressure matrix-assisted la

41 its of its applicability in an example of Er:YAG and Er:YLF dielectric crystals-potential radiation c

42 uld be performed only for the efficacy of Er:YAG laser due to the heterogeneity of the studies and th

43 with an ultrasonic scaler (metal tip) or Er:YAG laser (20.3 or 38.2 J/cm(2)) in non-contact mode.

44 ce does suggest that use of the Nd:YAG or Er:YAG wavelengths for treatment of chronic periodontitis m

45 on the "laser" factor were in the order: Er:YAG > Nd:YAG (p < 0.05), and on the "graphite" factor we

46 The Dunnett test showed that Er:YAG + HF had significantly higher tensile strength (p =

47 We conclude that Er:YAG laser preparation of dentin leaves a suitable surfac

48 and scanty plaque aggregates, whereas the Er:YAG laser (38.2 J/cm(2)) completely stripped away the pl

49 e ultrasonic scaler and </=0.03% with the Er:YAG laser (38.2 J/cm(2)).

50 The Er:YAG laser light resonantly excites O-H stretching vibrat

51 of 35 (28.6%) and six of 20 (30%) of the Er:YAG-laser-treated; and eight of 35 (22.8%) and four of 2

52 Thus Er:YAG laser treatment produces higher bond strength to res

53 showed additional advantages compared to Er:YAG in terms of less postoperative discomfort and pain.

54 g full-mouth subgingival debridement with Er:YAG laser application in the treatment of patients with

55 Newer wavelengths such as erbium:YAG are currently impractical.

56 To evaluate YAG laser vitreolysis vs sham vitreolysis for symptomati

57 procedures, such as yttrium aluminum garnet (YAG) capsulotomies or reduction of astigmatism and refra

58 and neodymium-doped yttrium-aluminum-garnet (YAG) laser capsulotomy, and surgical complications.

59 imity to his or her yttrium-aluminum-garnet (YAG) laser capsulotomy-providing ophthalmologist and opt

60 id-infrared holmium:yttrium-aluminum-garnet (YAG) laser has been shown to be effective in a variety o

61 n-ion laser, 532-nm yttrium-aluminum-garnet (YAG) laser, blue fluorescent light bulb, or blue light-e

62 ry driving distances and times to his or her YAG laser capsulotomy-providing Oklahoma ophthalmologist

63 eshold illuminance with both Nd: YAG and Ho: YAG was ineffective.

64 The Ho: YAG laser-treated surface (wavelength 2100 nm) did not s

65 0.11) to perform percutaneous DMR with an Ho:YAG laser at 2 J/pulse.

66 e six treated with balloon dilatation and Ho:YAG laser endoureterotomy, the success rate was 67% (58

67 Holmium:yttrium-aluminum-garnet (Ho:YAG) laser endoureterotomy is useful for other types of

68 tion and two with balloon dilatation plus Ho:YAG laser endoureterotomy, all successfully (57 months m

69 Our results suggest that Ho:YAG laser endoureterotomy should be a first line treatme

70 It is speculated that the Ho:YAG laser is coupling with absorbed water, and that the

71 2 kidney transplant patients managed with Ho:YAG laser endoureterotomy and/or percutaneous ureterosco

72 s were randomly assigned PTMR with a holmium:YAG laser plus continued medical treatment (n=110) or co

73 al ischemia is seen after TMR with a holmium:YAG laser.

74 ed in the left ventricle (LV) with a holmium:YAG laser.

75 n the anterior left ventricle with a Holmium:YAG laser.

76 +/-9.4% of baseline, p = 0.02) after holmium:YAG TMR.

77 Both holmium:YAG and CO2 lasers are associated with increased MWC and

78 ent holmium:yttrium-aluminum-garnet (holmium:YAG) (n = 12) or carbon dioxide (CO2) (n = 12) laser TMR

79 h a holmium:yttrium-aluminum-garnet (holmium:YAG) laser (n = 5), TMI (n = 5), or sham redo-thoracotom

80 The safety and efficacy of holmium:YAG laser lithotripsy make it the intracorporeal lithotr

81 (217.4+/-44.2% of baseline 6 h post-holmium:YAG TMR, p = 0.05; 206+/-36.7% of baseline 6 h post-CO2

82 The holmium:YAG (Yttrium-Aluminum-Garnet) laser lithotripter is able

83 The holmium:YAG laser lithotripter is the method of choice for flexi

84 ase in MWC (1.4+/-0.3% increase with holmium:YAG, p = 0.004; 1+/-0.2% increase with CO2, p = 0.002) a

85 peratures from 1900 to 3200 kelvin with a Nd-YAG laser in diamond-anvil cells to study the phase rela

86 s, pulse duration 0.2 ms) obtained from a Nd-YAG laser, which heated the fiber and bathing buffer sol

87 Cells were irradiated with a pulsed Nd/YAG laser at 355 nm using 0-160 J per cm2.

88 ed on the surface after application of a Nd: YAG laser interference pattern to a surface that was fir

89 difference (P < 0.05) between IOP before Nd: YAG laser capsulotomy (16 mmHg +/- 3 mmHg) and the respe

90 t layer, threshold illuminance with both Nd: YAG and Ho: YAG was ineffective.

91 , in a period of 2 to 6 months following Nd: YAG laser caspulotomy.

92 ion spectra using a frequency-quadrupled Nd: YAG laser on samples of NO, O2, and methyl iodide; a use

93 The Nd: YAG laser (wavelength 1060 nm) produced significant recr

94 Nd:YAG laser hyaloidotomy is an inexpensive, effective and

95 Nd:YAG laser hyaloidotomy was successful in 19 eyes(86.4%).

96 nderwent treatment with CO2 laser (n=18), Nd:YAG laser (n=18), or sham thoracotomy control (n=10) to

97 he standard MALDI lasers emitting at 355 (Nd:YAG) or 337 nm (N(2) laser).

98 3) CO2 laser with char layer removed; 4) Nd:YAG laser with air/water surface cooling, and char layer

99 2); 4) CO2 laser at 6 W (1,032 J/cm2); 5) Nd:YAG laser at 5 W (714 J/cm2); and 6) Nd:YAG laser at 7 W

100 urface cooling, and char layer intact; 5) Nd:YAG laser with air/water surface cooling, and char layer

101 ) Nd:YAG laser at 5 W (714 J/cm2); and 6) Nd:YAG laser at 7 W (1,000 J/cm2).

102 e cooling, and char layer removed; and 6) Nd:YAG laser without air/water surface cooling, and char la

103 er ablation with the second harmonic of a Nd:YAG laser (532 nm) at 13.5 mJ/pulse and a repetition rat

104 th an interference pattern generated by a Nd:YAG laser allows the activation of 1.7-micron-wide bands

105 Frequency doubling of a Nd:YAG laser line resulted in a colinear beam of both lambd

106 A Nd:YAG laser with wavelengths of 532 nm or 1064 nm was used

107 A Nd:YAG operating at lambda=532 nm and an energies per pulse

108 es with PCO increased significantly after Nd:YAG laser capsulotomy, as shown by AS-OCT, a reliable an

109 Three days after Nd:YAG laser capsulotomy, mean ACD, AOD500, AOD750, and ACA

110 mography (AS-OCT) before and 3 days after Nd:YAG laser capsulotomy.

111 veloped chronic open-angle glaucoma after Nd:YAG vitreolysis for symptomatic floaters presenting with

112 b strongly near the second harmonic of an Nd:YAG laser (532 nm), hold promise for manipulating and in

113 of the magnetooptical (MO) Q-switch in an Nd:YAG laser cavity is performed.

114 The PCO scores and Nd:YAG capsulotomy rate.

115 um-garnet (Er:YAG), pulsed dye (PDL), and Nd:YAG have been investigated as alternative treatments for

116 interventions including IOL exchange and Nd:YAG laser anterior capsulotomy.

117 response was severely delayed by CO2 and Nd:YAG laser irradiation of bone, even in the presence of a

118 ting from continuous mode shallow CO2 and Nd:YAG laser pulmonary parenchymal exposures applied in rab

119 nd without removal of the char layer, and Nd:YAG laser with char layer removed and with and without u

120 r:YAG laser, 72%-100%; PDL, 47%-100%; and Nd:YAG laser, 46%-100%).

121 erface during laser ablation with CO2 and Nd:YAG lasers used with and without (w/wo) air/water coolan

122 CO2 and Nd:YAG lasers were used w/wo coolant at power settings of 4

123 tudied for this purpose are CO2, PDL, and Nd:YAG, and of these, PDL has the fewest adverse effects.

124 Before Nd:YAG laser capsulotomy, mean ACD, AOD500, AOD750, and ACA

125 A compact Nd:YAG laser with an output at 1.06 microns corresponding t

126 s were first optically trapped (with a CW Nd:YAG laser at 1064 nm) and then photolyzed with a single

127 that uses a Q-switched, frequency-doubled Nd:YAG (neodymium, yttrium, aluminum, garnet) laser operati

128 phic recording, using a frequency-doubled Nd:YAG laser (532 nm).

129 phic recording, using a frequency doubled Nd:YAG laser (532 nm).

130 asmon absorption with a frequency doubled Nd:YAG laser (lambda = 532 nm) results in optically directe

131 NA FSFC using a compact frequency-doubled Nd:YAG laser excitation source.

132 A frequency-doubled Nd:YAG laser pulse was focused at the interface of the glas

133 aphic recording using a frequency-doubled Nd:YAG laser.

134 de) or photodisruptive (frequency doubled Nd:YAG) lasers, is still reserved for patients who do not i

135 isual outcome and complications following Nd:YAG laser hyaloidotomy for premacular subhyaloid hemorrh

136 sure range from 18 to 38 months following Nd:YAG vitreolysis.

137 uence the total-pulse energy required for Nd:YAG capsulotomy.

138 othesized that lung injury is deeper from Nd:YAG laser exposures than CO2 exposures because of deeper

139 neodymium-doped yttrium aluminium garnet (Nd:YAG) capsulotomy rate of a square-edge (SE) polymethylme

140 neodymium-doped yttrium aluminum garnet (ND:YAG) laser was used to create light burns on the retina

141 r + HF, Nd:YAG laser + HF, and Graphite + Nd:YAG laser + HF.

142 laser" factor were in the order: Er:YAG > Nd:YAG (p < 0.05), and on the "graphite" factor were in the

143 d picosecond 532 nm green second-harmonic Nd:YAG, and the femtosecond NIR 800 nm Ti:sapphire laser wi

144 laser + HF, Graphite + Er:YAG laser + HF, Nd:YAG laser + HF, and Graphite + Nd:YAG laser + HF.

145 ng a frequency doubled Q-switched (10 Hz) Nd:YAG laser at 532 nm.

146 ding of the photodisruptive mechanisms in Nd:YAG capsulotomy.

147 Ablative treatments, including Nd:YAG laser, photodynamic therapy, and thermal contact tre

148 nder nanosecond-pulsed laser irradiation (Nd:YAG, 355 nm), the efficiency of Au cluster ion formation

149 tiple pulses from a 3 x omega mode-locked Nd:YAG laser, columnar structures were formed on the surfac

150 high-repetition-rate (36.6 kHz) microchip Nd:YAG laser.

151 roseconds within plasmas formed by 300-mJ Nd:YAG laser pulses.

152 Therefore, a nanosecond Nd:YAG laser beam was focused into a flux of helium charged

153 , small, and "turn-key" Q-switched 532-nm Nd:YAG laser as a source for nonlinear, direct-write protei

154 inoculation site with a low power 532 nm Nd:YAG laser enhanced the permeability of the capillary ben

155 Rabbits were irradiated with a 532-nm Nd:YAG laser with a beam diameter of 330 microm at the reti

156 alexandrite laser, or Q-switched 1064-nm Nd:YAG laser.

157 e (FTICR) mass spectrometer with a 355-nm Nd:YAG UV laser, in the positive ion mode.

158 due to the isotropic crystal structure of Nd:YAG and the fact that the MO Q-switch incorporating the

159 The 5-year incidence of Nd:YAG laser capsulotomy in this cohort was determined thro

160 open-angle glaucoma is a complication of Nd:YAG vitreolysis for symptomatic floaters that may presen

161 xposures because of deeper penetration of Nd:YAG wavelength light.

162 The design is based on a pulsed Nd:YAG laser which takes advantage of gating techniques to

163 ike heat loading was applied via a pulsed Nd:YAG millisecond laser on a pristine molybdenum (Mo) surf

164 quasi-continuous-wave (QCW) diode-pumped Nd:YAG laser cavity, which is shortened to 10 mm in length

165 e from a Q-switched, frequency-quadrupled Nd:YAG laser that was modified to have an approximately fla

166 nm excimer or 266 nm frequency-quadrupled Nd:YAG lasers to ablate and ionize particles in a single st

167 is mediated using a frequency-quintupled Nd:YAG laser (213 nm) operated at a rather low laser fluenc

168 he application of a 1-kHz repetition rate Nd:YAG laser (355 nm, <500-ps pulse widths) for atmospheric

169 zed tracheobronchial amyloidosis required Nd:YAG (neodymium:yttrium-aluminum-garnet) laser therapy fo

170 14 eyes (34.2%); 12 eyes (29.3%) required Nd:YAG capsulotomy.

171 ior capsule opacification (PCO) requiring Nd:YAG laser capsulotomy in a representative mixed cohort o

172 ents subsequently requiring/not requiring Nd:YAG laser capsulotomy.

173 ade by splitting and recombining a single Nd:YAG laser beam.

174 quency-doubled, diode-pumped, solid-state Nd:YAG laser for rapid and sensitive DNA fragment sizing.

175 (41 of 52 [79%]), followed by Q-switched Nd:YAG (30 of 52 [58%]).

176 A Q-switched Nd:YAG laser at 355 nm was used to ablate a high-alloy stai

177 he range of 200-975nm by using Q-switched Nd:YAG laser at 532nm (4ns, 10Hz) attached to echelle spect

178 nanosecond laser pulses from a Q-switched Nd:YAG laser at lambda = 532 nm to generate cavitation bubb

179 Q switched Nd:YAG laser was applied to create an opening in the poster

180 nsively studied device was the Q-switched Nd:YAG laser, which has shown promising results based on mu

181 laser pulses of 532 nm from a Q-switched Nd:YAG laser.

182 distinct and slightly deeper in CO2 than Nd:YAG-treated animals (p<0.02) despite the shallower depth

183 reas of direct exposure, and suggest that Nd:YAG laser exposure at these settings may cause shallower

184 anged from 8.0 to 11.1 degrees C with the Nd:YAG and 1.4 to 2.1 degrees C with the CO2.

185 defects in the rat tibia created with the Nd:YAG and CO2 in the presence of a surface cooling spray o

186 approximately 119 to 139 seconds for the Nd:YAG and CO2, respectively.

187 used lasers for dental procedures are the Nd:YAG and CO2.

188 es such as those by Raman-shifting of the Nd:YAG fundamentals, our approach has the advantage of bein

189 The Nd:YAG laser can be used to lyse residual cortex after unco

190 periodontal soft tissue surgery with the Nd:YAG laser could be damaging, especially if the exposure

191 n the total-pulse energy required for the Nd:YAG laser posterior capsulotomy.

192 Specimens treated with the Nd:YAG laser using an air/water surface coolant exhibited a

193 Before treatment with the Nd:YAG laser, all patients had subjective visual complaints

194 sed trapping wavelength, 1064 nm from the Nd:YAG laser, strongly reduced clonability, depending upon

195 The Nd:YAG LGP is a safe and effective procedure for lowering I

196 ent evidence does suggest that use of the Nd:YAG or Er:YAG wavelengths for treatment of chronic perio

197 n the total-pulse energy required for the Nd:YAG procedure was analyzed.

198 47 eyes with PCO scheduled for the Nd:YAG procedure were examined and divided into four catego

199 Among the modalities for its treatment, Nd:YAG laser hyaloidotomy is a non invasive method enabling

200 Patients who had undergone Nd:YAG laser capsulotomy were significantly younger (median

201 ior capsule opacification (PCO) underwent Nd:YAG laser capsulotomy.

202 Consecutive patients who underwent Nd:YAG laser treatment for residual cortex at the Kellogg E

203 with patent internal ostia and underwent Nd:YAG LGP, followed by a 5-fluorouracil injection.

204 ure to optical trapping wavelengths using Nd:YAG (1064 nm) and tunable titanium-sapphire (700-990 nm)

205 taract surgery and is mostly treated with Nd:YAG laser capsulotomy.

206 ary explosives that can be initiated with Nd:YAG laser light at lower energy thresholds than those of

207 Nine-year Nd:YAG capsulotomy rates were 2% for SE-PMMA IOLs versus 37

208 ing frequency-doubled double-pulse neodymium:YAG laser lithotripsy.

209 avior is studied in erbium-doped Y3 Al5 O12 (YAG) garnets synthesized by solid-state reactions.

210 istance of time following the application of YAG laser capsulotomy.

211 striking effect on the optical properties of YAG:Er(3+) .

212 to undergo surgery, 40 (15.7%) required only YAG-Laser and 14 (5.5%) required a spectacle prescriptio

213 as cerium-doped yttrium aluminum garnet or (YAG):Ce(3+), coupled with a blue-emitting InGaN/GaN diod

214 ly assigned to YAG laser vitreolysis or sham YAG (control).

215 The YAG laser group reported greater symptomatic improvement

216 e, 5.6; 95% CI, 0.5-10.8; P = .03) among the YAG laser group.

217 udy (mean [SD] age, 61.4 [8.0] years for the YAG laser group and 61.1 [6.6] years for the sham group)

218 visual acuity changed by -0.2 letters in the YAG laser group and by -0.6 letters in sham group (diffe

219 A total of 19 patients (53%) in the YAG laser group reported significantly or completely imp

220 In the YAG laser group, the 10-point visual disturbance score i

221 re was no difference in geographic access to YAG laser capsulotomy whether performed by an Oklahoma o

222 Patients were randomly assigned to YAG laser vitreolysis or sham YAG (control).

223 as a donor consensus in P. carinii, whereas YAG serves as an acceptor consensus.